Vincent J. Angotti
2021
In 2021, Vincent J. Angotti earned a total compensation of $2.4M as Chief Executive Officer at AcelRx Pharmaceuticals, a 39% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $267,347 |
|---|---|
| Option Awards | $1,156,667 |
| Salary | $636,540 |
| Stock Awards | $376,000 |
| Other | $11,400 |
| Total | $2,447,954 |
Angotti received $1.2M in option awards, accounting for 47% of the total pay in 2021.
Angotti also received $267.3K in non-equity incentive plan, $636.5K in salary, $376K in stock awards and $11.4K in other compensation.
Rankings
In 2021, Vincent J. Angotti's compensation ranked 5,234th out of 12,406 executives tracked by ExecPay. In other words, Angotti earned more than 57.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,234 out of 12,406 | 58th |
Division Manufacturing | 2,197 out of 5,492 | 60th |
Major group Chemicals And Allied Products | 954 out of 2,368 | 60th |
Industry group Drugs | 852 out of 2,089 | 59th |
Industry Pharmaceutical Preparations | 611 out of 1,536 | 60th |
Source: SEC filing on June 3, 2022.
Angotti's colleagues
We found two more compensation records of executives who worked with Vincent J. Angotti at AcelRx Pharmaceuticals in 2021.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019